Elsevier

The Lancet

Volume 347, Issue 8995, 20 January 1996, Pages 143-146, nil, nil, nil, 146-147
The Lancet

Randomised trial of oral morphine for chronic non-cancer pain

https://doi.org/10.1016/S0140-6736(96)90339-6Get rights and content

Abstract

Summary

Background The use of opioid analgesics for chronic non-cancer pain is controversial. Some surveys report good pain relief and improvement in performance while others suggest a poor outcome with a propensity to psychological dependence or addiction.

Methods We undertook a randomised double-blind crossover study to test the hypothesis that oral morphine relieves pain and improves the quality of life in patients with chronic regional pain of soft tissue or musculoskeletal origin who have not responded to codeine, antiinflammatory agents, and antidepressants. Morphine was administered as a sustained-release preparation in doses up to 60 mg twice daily and compared with benztropine (active placebo) in doses up to 1 mg twice daily over three-week titration, six-week evaluation, and two-week washout phases. Pain intensity, pain relief, and drug liking were rated weekly and psychological features, functional status, and cognition were assessed at baseline and at the end of each evaluation phase.

Findings After dose titration in the 46 patients who completed the study, the mean daily doses of drugs were morphine 83·5 mg and benztropine 1·7 mg. On visual analogue scales, the morphine group showed a reduction in pain intensity relative to placebo in period I (p=0·01) and this group also fared better in a crossover analysis of the sum of pain intensity differences from baseline (p=0·02). No other significant differences were detected.

Interpretation In patients with treatment-resistant chronic regional pain of soft-tissue or musculoskeletal origin, nine weeks of oral morphine in doses up to 120 mg daily may confer analgesic benefit with a low risk of addiction but is unlikely to yield psychological or functional improvement.

References (36)

  • Se Ward et al.

    Application of the American Pain Society quality assurance standards

    Pain

    (1994)
  • Ar Jadad et al.

    Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia

    Lancet

    (1992)
  • Rc Kupers et al.

    Morpine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain

    Pain

    (1991)
  • De Joranson et al.

    The McNeil National Pain Study

    (1994)
  • A. Taub

    Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin

  • Aj Boukoms et al.

    Chronic nonmalignant pain teated with long-term oral narcotic analgesics

    Ann Clin Psychiatry

    (1992)
  • Fs Tennant et al.

    Narcotic maintenance for chronic pain: medical and legal guidelines

    Postgrad Med

    (1983)
  • Cited by (389)

    • The Role of Intrathecal Pumps in Nonmalignant Pain

      2022, Neurosurgery Clinics of North America
    View all citing articles on Scopus
    View full text